Cultiva Cannabis Congress 2019

Welcome to the 12. Cultiva Cannabis Congress!

THE hotspot concerning medicine, law, politics and culture. International experts will talk about current developments, researches, changes and trends.

International high-profile speakers from the fields of science, research, medicine and politics will be speaking on a wide range of topics such as cannabis in medicine, as raw material, legal issues, as well as health and cultural aspects. Once again, the Congress will focus on the wide and evolving area of cannabis in medicine as this topic gains more and more interest well as the legal regulations, which have changed in many countries in the past months.

Recht Freitag Medizin Samstag Gesundheit Sonntag

Law & traffic safety

Medical Cannabis

Health & cultural aspects



Interviews with our speakers from the 11. Cultiva Cannabis Congress 2018 (in German language)















Thank you for you participation!
Your Cultiva Cannabis Congress-Team

Prof. Dr. Tamara Lah Turnsek

Director of the NIB, Department of Genetic Toxicology and Cancer Biology, Slovenia

LECTURE: Cannabis as novel drug for longer survival of cancer patients

Prof. Tamara Lah Turnšek holds a BS in Organic Chemistry, a PhD in Biochemistry, both from the University of Ljubljana. Lah has been the Director of National Institute of Biology (NIB) in Ljubljana since 1996, leading the 3rd largest public research institution for natural sciences in Slovenia. She established the Department of Genetic Toxicology and Cancer Biology and is the Programme leader of this research group. Recently, her research has focused on brain tumours - glioma and the role of normal stem cells in tumour progression and therapy.

In her lecture whe will give insights to her studies and findings, using cannabis als drug for cancer patients:

Cannabinoids have a role in the treatment of cancer as palliative interventions against nausea, vomiting, pain, anxiety, and sleep disturbances. THC and nabilone are also used for anorexia and weight loss.
As cannabinoids receptors are highly expressed in brain and in particular in brain tumors, the glioblastoma, relatively more attention has been paid to understand and prove the effects of cannabinoids in this type of cancer. The in vitro studies have clearly shown the anti-proliferative effects, cell death and at lower doses reduced invasion of glioblastoma cells.

Lecture in English  English

>> to the speakers list

>> to the agenda